Toll-like receptors and macrophage activation in atherosclerosis.

Atherosclerosis is a multi-factorial inflammatory disease and is the primary initiator of coronary artery and cerebrovascular disease. Initially believed to be exclusively lipid-driven, recent evidence demonstrates that inflammation is a significant driving force of the disease. Cellular components...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Seneviratne, A, Sivagurunathan, B, Monaco, C
Format: Journal article
Sprache:English
Veröffentlicht: 2012
_version_ 1826275517267968000
author Seneviratne, A
Sivagurunathan, B
Monaco, C
author_facet Seneviratne, A
Sivagurunathan, B
Monaco, C
author_sort Seneviratne, A
collection OXFORD
description Atherosclerosis is a multi-factorial inflammatory disease and is the primary initiator of coronary artery and cerebrovascular disease. Initially believed to be exclusively lipid-driven, recent evidence demonstrates that inflammation is a significant driving force of the disease. Cellular components of innate immunity, for example monocytes and macrophages, play a predominant role in atherosclerosis. Toll-like receptors (TLRs) are the most characterised innate immune receptors and recent evidence demonstrates an important role in atherogenesis. Engagement of TLRs results in the transcription of pro-inflammatory cytokines, foam cell formation and activation of adaptive immunity. Recently they have also been implicated in protection from vascular disease. In this review, we detail the role of the innate immune system, specifically macrophages and TLR signalling, in atherosclerosis and acute cardiovascular complications, and thereby identify the potential of TLRs to act as therapeutic targets.
first_indexed 2024-03-06T22:59:55Z
format Journal article
id oxford-uuid:61bedd18-d2e7-4108-bb6c-d079ec1a60b0
institution University of Oxford
language English
last_indexed 2024-03-06T22:59:55Z
publishDate 2012
record_format dspace
spelling oxford-uuid:61bedd18-d2e7-4108-bb6c-d079ec1a60b02022-03-26T18:01:53ZToll-like receptors and macrophage activation in atherosclerosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:61bedd18-d2e7-4108-bb6c-d079ec1a60b0EnglishSymplectic Elements at Oxford2012Seneviratne, ASivagurunathan, BMonaco, CAtherosclerosis is a multi-factorial inflammatory disease and is the primary initiator of coronary artery and cerebrovascular disease. Initially believed to be exclusively lipid-driven, recent evidence demonstrates that inflammation is a significant driving force of the disease. Cellular components of innate immunity, for example monocytes and macrophages, play a predominant role in atherosclerosis. Toll-like receptors (TLRs) are the most characterised innate immune receptors and recent evidence demonstrates an important role in atherogenesis. Engagement of TLRs results in the transcription of pro-inflammatory cytokines, foam cell formation and activation of adaptive immunity. Recently they have also been implicated in protection from vascular disease. In this review, we detail the role of the innate immune system, specifically macrophages and TLR signalling, in atherosclerosis and acute cardiovascular complications, and thereby identify the potential of TLRs to act as therapeutic targets.
spellingShingle Seneviratne, A
Sivagurunathan, B
Monaco, C
Toll-like receptors and macrophage activation in atherosclerosis.
title Toll-like receptors and macrophage activation in atherosclerosis.
title_full Toll-like receptors and macrophage activation in atherosclerosis.
title_fullStr Toll-like receptors and macrophage activation in atherosclerosis.
title_full_unstemmed Toll-like receptors and macrophage activation in atherosclerosis.
title_short Toll-like receptors and macrophage activation in atherosclerosis.
title_sort toll like receptors and macrophage activation in atherosclerosis
work_keys_str_mv AT seneviratnea tolllikereceptorsandmacrophageactivationinatherosclerosis
AT sivagurunathanb tolllikereceptorsandmacrophageactivationinatherosclerosis
AT monacoc tolllikereceptorsandmacrophageactivationinatherosclerosis